Dimerix Bioscience Pty Ltd
3 clinical trials · Sponsor
◉ Watch Dimerix Bioscience Pty Ltd
| Record | Firm | Date |
|---|---|---|
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB (NCT05183646) | Dimerix Bioscience Pty Ltd | 2022-05-30 |
| Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan (NCT03649152) | Dimerix Bioscience Pty Ltd | 2018-11-08 |
| Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan (NCT03627715) | Dimerix Bioscience Pty Ltd | 2018-11-06 |
Track Dimerix Bioscience Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.